Assessment of hearing dysfunction in patients with Graves’ disease and thyroid eye disease without or with teprotumumab

Published: 20 August 2024| Version 1 | DOI: 10.17632/772vxh6fyf.1
Contributor:
Terry Smith

Description

SUPPLEMENT Assessment of hearing dysfunction in patients with Graves’ disease and thyroid eye disease without or with teprotumumab

Files

Institutions

University of Michigan

Categories

Adverse Event, Hearing Loss

Licence